-
February 05, 2013
Luminex Corporation's (LMNX) fourth-quarter 2012 adjusted earnings of 12 cents per share (up 9% year over year) beat ...
-
January 16, 2013
Luminex Corporation (LMNX) recently revealed that it won clearance from the FDA for its xTAG Gastrointestinal ...
-
December 18, 2012
Luminex Corporation's (LMNX) third quarter 2012 adjusted earnings of $0.04 per share missed the Zacks Consensus ...
-
October 30, 2012
Luminex Corporation's (LMNX) third quarter 2012 adjusted (excluding one-time charges) earnings of 4 cents per share ...
-
September 17, 2012
We reiterate our Neutral recommendation on Luminex Corporation (LMNX) following its second quarter results. In the ...
-
September 07, 2012
Diagnostic testing technologies company, Luminex Corporation (LMNX) recently received a Technology Award from the ...
-
August 23, 2012
The market is currently down, with the Nasdaq decreasing 0.2%, the S&P 500 falling 0.4% and the Dow declining 0.6%. ...
-
August 10, 2012
Luminex Corporation (LMNX), a developer of biological testing technologies, recently announced that the Defense ...
-
July 31, 2012
Luminex Corporation (LMNX) reported second quarter 2012 adjusted (excluding one-time charges) earnings of 7 cents ...
-
July 23, 2012
This morning's trading has marked a bad day for the market so far. The Nasdaq has declined 1.9%; the S&P 500 has ...
-
July 13, 2012
On a bad day for the market, the Nasdaq has decreased 0.3%, the S&P 500 is down 0.3% and the Dow has fallen 0.4%. ...
-
July 10, 2012
Luminex Corporation (LMNX) recently announced a definitive deal to buy US-based diagnostic testing company, ...
-
July 09, 2012
It's been a bad morning for the market, with the Nasdaq down 0.3%, the S&P 500 falling 0.3% and the Dow decreasing ...
-
June 22, 2012
The decision of whether to buy Bio-Reference really comes down to an investor's confidence in the growth prospects ...
-
May 03, 2012
Mixed 1Q for Luminex, Profits Down - Analyst Blog
-
November 16, 2011
Meridian offers an impressive dividend, but a high valuation as well.
-
September 13, 2011
Caliper's rebound comes to an end with a premium take-out by PerkinElmer.
-
August 02, 2011
Cepheid is becoming a real player in MDx, but the valuation is way ahead.
-
July 07, 2011
Affymetrix continues to flounder with unexciting technology.
-
July 05, 2011
Immucor gets a fair price for its shareholders.
